We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Reset all filters
01 20Alfred E Tiefenbacher GmbH
02 5Pharmathen SA
03 92care4
04 6Abiogen Pharma Spa
05 7Actavis Inc
06 3Alkem Laboratories
07 6CHEMO
08 9Collegium Pharmaceutical
09 8ENDO OPERATIONS LTD.
10 7G.L. Pharma Gmbh
11 5GL Pharma
12 51Grunenthal
13 11Grünenthal GmbH
14 2Health Biotech
15 2Hubei Gedian Humanwell Pharmaceutical
16 5Johnson & Johnson Innovative Medicine
17 6Medical Valley
18 3Novagen Healthcare
19 10ORIFARM GROUP AS
20 9Orchid Pharma
21 7Precise Group
22 2RHODES PHARMACEUTICALS LP
23 3ROXANE
24 5Sandoz B2B
25 5Seqirus
26 1Vega Biotech Pvt. Ltd.
27 4West-ward Pharmaceutical Corp
28 24Blank
Reset all filters
01 1Antic-calc Tablet, Film Coated
02 20Depot tablet
03 10Depottablett
04 7ER TABLET
05 4ER Tablet
06 10Extended Release Tablets
07 12Extended-Release Tablet
08 17Film Coated Tablet
09 2Mixture, solution
10 4Oral Solution
11 5Prolonged Release Tablet
12 2SOLUTION;ORAL
13 12SR Tablet
14 3SRT
15 4Solution
16 2TAB
17 3TABLET
18 5TABLET (EXTENDED-RELEASE)
19 3TABLET (IMMEDIATE RELEASE)
20 14TABLET, EXTENDED RELEASE;ORAL
21 2TABLET; ORAL
22 12TABLET;ORAL
23 59Tablet
24 1Tablet, film-coated
25 1Tapentadolo 100Mg 30 Joined' Oral Use Rp
26 1Tapentadolo 150Mg 30 Joined' Oral Use Rp
27 1Tapentadolo 200Mg 30 Joined' Oral Use Rp
28 1Tapentadolo 250Mg 30 Joined' Oral Use Rp
29 1Tapentadolo 25Mg 40 Combined Oral Use Rp
30 1Tapentadolo 50Mg 30 Joined' Oral Use Rp
31 10XR Tablet
32 5Blank
Reset all filters
01 26Approved
02 1DISCN
03 34Deregistered
04 2EU Dossier Readiness-Q1 2020
05 4EU Dossier Readiness-Q3 2019
06 8Generic
07 9Generic EU CTD
08 5Originator
09 8RX
10 14Status- Early Development
11 12Under registration in India
12 112Blank
Reset all filters
01 160 Palexia Retard 100Mg Extended Release Tablets
02 160 Palexia Retard 150Mg Extended Release Tablets
03 160 Palexia Retard 200Mg Extended Release Tablets
04 160 Palexia Retard 250Mg Extended Release Tablets
05 160 Palexia Retard 25Mg Extended Release Tablets
06 160 Palexia Retard 50Mg Extended Release Tablets
07 160 Yantil Retard 100Mg Extended Release Tablets
08 160 Yantil Retard 150Mg Extended Release Tablets
09 160 Yantil Retard 200Mg Extended Release Tablets
10 160 Yantil Retard 250Mg Extended Release Tablets
11 160 Yantil Retard 25Mg Extended Release Tablets
12 160 Yantil Retard 50Mg Extended Release Tablets
13 3Ationdo
14 6Ationdo Depot
15 4NUCYNTA
16 5NUCYNTA ER
17 5NUCYNTA EXTENDED-RELEASE
18 3NUCYNTA IR
19 16Palexia
20 1Palexia 100 mg
21 1Palexia 50 mg
22 25Palexia Depot
23 5Palexia SR
24 1Palexia SR 100 mg
25 1Palexia SR 200 mg
26 1Palexia SR 50 mg
27 20Palexia depot
28 5TADOMON
29 5TAPELOD
30 16TAPENTADOL
31 5TAPENTADOL HYDROCHLORIDE
32 1Tapencet ER
33 6Tapentadol Depot Abiogen
34 6Tapentadol Depot G.L. Pharma
35 6Tapentadol Depot Medical Valley
36 1Tapentadol Gl Pharma
37 5Yantil
38 6Yantil Depot
39 64Blank
Reset all filters
01 5Australia
02 8Canada
03 20Germany
04 5Greece
05 34India
06 16Italy
07 34Norway
08 5South Africa
09 18Spain
10 60Sweden
11 30USA
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany